While the origins of the world’s first theme park are believed to trace back to sixteenth-century Denmark, the water park full of slides, pools and splash pads is a much more recent invention. The first Read more…
Founded in 1982 in Clute, Texas, this roadside chain has evolved from a regional fuel stop into one of the country’s most recognizable travel destinations. What began as a convenience store with gas pumps now Read more…
In my years running a large toy store in Manchester, Conn., the biggest challenge was having the right inventory for the holiday season. While some items, like train sets and certain board games, sell every Read more…
Johnson & Johnson (JNJ) spent 2025 proving it could lose a multibillion-dollar drug and still grow. Now it wants to show it can keep doing that for years. On June 13, the company reported results Read more…
Investors had been bracing for a deeper stock-market reset after the latest pullback exposed the cracks beneath the surface. Morgan Stanley says that fears might be going too far. According to a note shared with Read more…
Gold has surged at its fastest pace in two months following reports that Donald Trump has called off strikes against Iran. The precious metal extended its rally on news of a deal between Washington and Read more…
Launched out of JFK Airport with an inaugural flight to Fort Lauderdale in February 2000, JetBlue Airways flies to more than 100 U.S. and international destinations while positioning itself as the quintessential New York airline. Read more…
Palantir Technologies (PLTR) has spent years trying to convince Wall Street that it can become one of the most important software companies in the artificial intelligence boom. Its most recent action does just that. Palantir Read more…
Yum! Brands just made its boldest strategic move in years: saying goodbye to one of the most recognizable names in fast food. The Louisville-based restaurant giant announced on June 16 that it has agreed to Read more…
Eli Lilly (LLY) became the first pharmaceutical company to cross a $1 trillion market valuation in November last year, carried largely by its highly lucrative obesity and diabetes medications, such as Mounjaro and Zepbound. Now Read more…